Ofloxacine Unit Dose Stulln

Ofloxacin, the active ingredient in Ofloxacine Unit Dose Stulln, is a fluoroquinolone antibiotic presented as a unit dose for oral use. It treats a variety of bacterial infections in adults and children when prescribed by a healthcare professional.

GNH USA supplies Ofloxacine Unit Dose Stulln as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ofloxacin is a broad‑spectrum antibacterial that is active against Gram‑negative and Gram‑positive organisms in several infection sites. - Urinary tract infection: helps eradicate the causative bacteria and relieve symptoms. - Respiratory tract infection: reduces bacterial load in conditions such as acute exacerbations of chronic bronchitis. - Skin and soft‑tissue infection: aids in clearing infection and promoting wound healing. - Gonorrhoea: eliminates Neisseria gonorrhoeae and prevents disease progression. - Prostatitis: assists in eradicating the infecting organism within prostatic tissue.

Adverse reactions to ofloxacin may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Nausea: mild stomach upset often reported. - Diarrhea: loose stools occurring during treatment. - Headache: transient head pain experienced by some patients. - Dizziness: occasional sensation of light‑headedness. - Rash: mild skin erythema or itching. - Photosensitivity: increased skin sensitivity to sunlight.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or rupture, especially in the Achilles. - QT prolongation: irregular heart rhythm that may lead to fainting. - Severe allergic reaction: anaphylaxis with hives, swelling and breathing difficulty. - Peripheral neuropathy: numbness or tingling in extremities. - Hepatotoxicity: elevated liver enzymes or jaundice. - Clostridioides difficile infection: severe colitis following antibiotic use.

Before prescribing Ofloxacine Unit Dose Stulln, clinicians should evaluate patient history and potential risk factors. - Renal impairment: adjust dose or monitor renal function. - Hepatic impairment: use with caution in patients with liver disease. - History of tendon disorders: avoid in patients with prior tendon injury. - Cardiac risk: assess QT interval in patients with known arrhythmias. - Pregnancy and lactation: weigh benefits against potential risks. - Store at below 25°C: keep in the original packaging, protect from moisture and light.

Ofloxacin can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce ofloxacin absorption. - Warfarin: may increase anticoagulant effect and bleeding risk. - Cyclosporine: heightened risk of tendon toxicity.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase risk of central nervous system effects. - Theophylline: ofloxacin can raise serum theophylline concentrations. - Oral contraceptives: may reduce contraceptive effectiveness.